FDA announces New Safety Measures for Duragesic (Transdermal Fentanyl)

Share Article

On July 9th, 2012 the US FDA announced new safety measures for a class of opioid medications, including Duragesic (transdermal Fentanyl). Opioids, when prescribed by physicians to patients who should not receive them, or when used improperly or for recreational purposes, can cause serious harm, including overdose and death. Fentanyl (brand names Duragesic, Onsolis and others) is a potent synthetic narcotic analgesic used to treat breakthrough cancer pain. According to court documents, on June 19th, 2012, Tracy King filed a wrongful death claim at Philadelphia’s Common Pleas Court (case no. 120602334) alleging that her sister’s death was caused by a Fentanyl pain patch. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Fentanyl severe adverse events. [http://www.attorneyone.com/fentanyl/ .

Fentanyl: severe adverse events threat

Fentanyl: severe adverse events threat

When too much is taken, the risk of overdose is serious and it can cause death

The media spotlight is often a double-edged sword. No one knows this better than people who suffer from Fentanyl Patch adverse events. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

On July 9th, 2012 the US FDA announced new safety measures for a class of opioid medications, including Duragesic (transdermal Fentanyl). Opioids, when prescribed by physicians to patients who should not receive them, or when used improperly or for recreational purposes, can cause serious harm, including overdose and death. Fentanyl (brand names Duragesic, Onsolis and others) is a potent synthetic narcotic analgesic used to treat breakthrough cancer pain and is commonly used in pre-procedures as a pain reliever as well as an anesthetic. "When too much is taken, the risk of overdose is serious and it can cause death,” says Sharon Hertz, M.D., deputy director of FDA's Division of Anesthesia, Analgesia and Addiction Products.

According to court documents, on June 19th, 2012, Tracy King filed a wrongful death claim at Philadelphia’s Common Pleas Court (case no. 120602334) alleging that her sister’s death was caused by a Fentanyl pain patch. In the complaint she claims that her sister died in June 2010 and the cause of death was Fentanyl toxicity.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of severe adverse events from Fentanyl, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat from Fentanyl remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

On April 18th 2012, the US FDA reminded patients, caregivers, and healthcare professionals of the importance of appropriate storage, use, application, and disposal of Fentanyl patches (including Duragesic and generic products) to prevent potential life-threatening harm from accidental exposure to the active ingredient, Fentanyl.

AttorneyOne.com has further information on Fentanyl lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/7/prweb9679489.htm.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sean Burke
Visit website